MARKET

CTBO

CTBO

Cantabio Pharmac
EXMKT
1.010
NaN%
Closed 09:30 05/21 EDT
OPEN
--
PREV CLOSE
1.010
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.010
52 WEEK LOW
1.010
MARKET CAP
22.77K
P/E (TTM)
-0.0057
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CTBO last week (0512-0516)?
Weekly Report · 2d ago
Weekly Report: what happened at CTBO last week (0505-0509)?
Weekly Report · 05/12 10:11
Weekly Report: what happened at CTBO last week (0428-0502)?
Weekly Report · 05/05 10:11
Weekly Report: what happened at CTBO last week (0421-0425)?
Weekly Report · 04/28 10:16
Weekly Report: what happened at CTBO last week (0414-0418)?
Weekly Report · 04/21 10:16
Weekly Report: what happened at CTBO last week (0407-0411)?
Weekly Report · 04/14 10:11
Weekly Report: what happened at CTBO last week (0331-0404)?
Weekly Report · 04/07 10:10
Weekly Report: what happened at CTBO last week (0324-0328)?
Weekly Report · 03/31 10:16
More
About CTBO
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company. The Company is focused on commercializing therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases. The Company’s small molecule therapy candidates program (CB101) and protein therapy candidate (CB201) targets Parkinson’s disease and a range of neurodegenerative diseases including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease and stroke. It also has two additional small molecule pharmacological chaperone programs for the treatment of Alzheimer’s Disease (and other related dementias); CB301, targeting the Tau protein, for the development of Alzheimer’s therapeutics, and CB401, targeting the Aß peptide in Alzheimer’s drug research. The Company’s strategy integrates therapeutic focus on targeting family biophysics and drug discovery technology.

Webull offers Cantabio Pharmaceuticals Inc stock information, including EXMKT: CTBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTBO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTBO stock methods without spending real money on the virtual paper trading platform.